149 related articles for article (PubMed ID: 9889208)
1. Development of a firefly luciferase-based assay for determining antimicrobial susceptibility of Mycobacterium avium subsp. paratuberculosis.
Williams SL; Harris NB; Barletta RG
J Clin Microbiol; 1999 Feb; 37(2):304-9. PubMed ID: 9889208
[TBL] [Abstract][Full Text] [Related]
2. Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis.
Foley-Thomas EM; Whipple DL; Bermudez LE; Barletta RG
Microbiology (Reading); 1995 May; 141 ( Pt 5)():1173-1181. PubMed ID: 7773411
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs.
Krishnan MY; Manning EJ; Collins MT
J Antimicrob Chemother; 2009 Aug; 64(2):310-6. PubMed ID: 19457932
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications.
Savarino E; Bertani L; Ceccarelli L; Bodini G; Zingone F; Buda A; Facchin S; Lorenzon G; Marchi S; Marabotto E; De Bortoli N; Savarino V; Costa F; Blandizzi C
Expert Opin Biol Ther; 2019 Feb; 19(2):79-88. PubMed ID: 30574820
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis.
Wong SY; Grant IR; Friedman M; Elliott CT; Situ C
Appl Environ Microbiol; 2008 Oct; 74(19):5986-90. PubMed ID: 18676709
[TBL] [Abstract][Full Text] [Related]
6. Growth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis.
Parrish NM; Ko CG; Dick JD; Jones PB; Ellingson JL
Clin Med Res; 2004 May; 2(2):107-14. PubMed ID: 15931343
[TBL] [Abstract][Full Text] [Related]
7. Effects of interactions of antibacterial drugs with each other and with 6-mercaptopurine on in vitro growth of Mycobacterium avium subspecies paratuberculosis.
Krishnan MY; Manning EJ; Collins MT
J Antimicrob Chemother; 2009 Nov; 64(5):1018-23. PubMed ID: 19759042
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Seroreactive Antigens in Johne's Disease Cattle by Using the Mycobacterium tuberculosis Protein Array.
Bannantine JP; Campo JJ; Li L; Randall A; Pablo J; Praul CA; Raygoza Garay JA; Stabel JR; Kapur V
Clin Vaccine Immunol; 2017 Jul; 24(7):. PubMed ID: 28515134
[TBL] [Abstract][Full Text] [Related]
9. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
Shafran I; Kugler L; El-Zaatari FA; Naser SA; Sandoval J
Dig Liver Dis; 2002 Jan; 34(1):22-8. PubMed ID: 11930899
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antimicrobial activities of gallium nitrate and gallium maltolate against Mycobacterium avium subsp. paratuberculosis in vitro.
Fecteau ME; Aceto HW; Bernstein LR; Sweeney RW
Vet J; 2014 Oct; 202(1):195-7. PubMed ID: 25155307
[TBL] [Abstract][Full Text] [Related]
11. Generation and screening of a comprehensive Mycobacterium avium subsp. paratuberculosis transposon mutant bank.
Rathnaiah G; Lamont EA; Harris NB; Fenton RJ; Zinniel DK; Liu X; Sotos J; Feng Z; Livneh-Kol A; Shpigel NY; Czuprynski CJ; Sreevatsan S; Barletta RG
Front Cell Infect Microbiol; 2014; 4():144. PubMed ID: 25360421
[TBL] [Abstract][Full Text] [Related]
12. Isolation of high-affinity single-chain antibodies against Mycobacterium avium subsp. paratuberculosis surface proteins from sheep with Johne's disease.
Berger S; Hinz D; Bannantine JP; Griffin JF
Clin Vaccine Immunol; 2006 Sep; 13(9):1022-9. PubMed ID: 16960114
[TBL] [Abstract][Full Text] [Related]
13. Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium.
Cooksey RC; Morlock GP; Beggs M; Crawford JT
Antimicrob Agents Chemother; 1995 Mar; 39(3):754-6. PubMed ID: 7793886
[TBL] [Abstract][Full Text] [Related]
14. Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol.
Rastogi N; Goh KS; Labrousse V
Antimicrob Agents Chemother; 1992 Dec; 36(12):2843-6. PubMed ID: 1482157
[TBL] [Abstract][Full Text] [Related]
15. "In vitro" activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis.
Zanetti S; Molicotti P; Cannas S; Ortu S; Ahmed N; Sechi LA
Ann Clin Microbiol Antimicrob; 2006 Nov; 5():27. PubMed ID: 17107610
[No Abstract] [Full Text] [Related]
16. Characterization of novel coding sequences specific to Mycobacterium avium subsp. paratuberculosis: implications for diagnosis of Johne's Disease.
Paustian ML; Amonsin A; Kapur V; Bannantine JP
J Clin Microbiol; 2004 Jun; 42(6):2675-81. PubMed ID: 15184451
[TBL] [Abstract][Full Text] [Related]
17. New method of serological testing for Mycobacterium avium subsp. paratuberculosis (Johne's disease) by flow cytometry.
Eda S; Elliott B; Scott MC; Waters WR; Bannantine JP; Whitlock RH; Speer CA
Foodborne Pathog Dis; 2005; 2(3):250-62. PubMed ID: 16156706
[TBL] [Abstract][Full Text] [Related]
18. Invasion and persistence of Mycobacterium avium subsp. paratuberculosis during early stages of Johne's disease in calves.
Wu CW; Livesey M; Schmoller SK; Manning EJ; Steinberg H; Davis WC; Hamilton MJ; Talaat AM
Infect Immun; 2007 May; 75(5):2110-9. PubMed ID: 17296749
[TBL] [Abstract][Full Text] [Related]
19. Binding of bovine growth hormone to. Mycobacterium avium ss paratuberculosis.
Feola RP; Czuprynski CJ
Comp Immunol Microbiol Infect Dis; 2000 Jul; 23(3):153-62. PubMed ID: 10855661
[TBL] [Abstract][Full Text] [Related]
20. Temporal patterns and quantification of excretion of Mycobacterium avium subsp paratuberculosis in sheep with Johne's disease.
Whittington RJ; Reddacliff LA; Marsh I; McAllister S; Saunders V
Aust Vet J; 2000 Jan; 78(1):34-7. PubMed ID: 10736683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
